Home › Chemotherapy › Which Chemotherapy Drugs — Affect Fertility?

Fertility and cancer treatment

Which Chemotherapy Drugs Affect Fertility?

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

Your oncologist just named a chemotherapy drug, and one of your first thoughts may be whether you will still be able to have children. That fear is valid, and the answer depends heavily on which drug is being used. Some chemotherapy drugs carry far higher fertility risk than others — and the conversation about it needs to happen before treatment starts.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

Prescription-only medicine.

Chemotherapy is a prescription-only treatment given under direct specialist supervision in a hospital or authorised day-care unit. No chemotherapy regimen should be started, adjusted, or stopped based on anything read online. It is not suitable for everyone — see who this is not for below.

Talk to an oncologist

Leave your details and a member of the oncology team will call you back to answer questions about your treatment plan.

No charge for the call, and no obligation to book anything.

412Chemotherapy pages, written and reviewed

17Oncologists on the panel

10Centres across Hyderabad

41Locations across two states

In short

Alkylating agents — including cyclophosphamide, busulfan, and chlorambucil — carry the highest fertility risk of any chemotherapy group. Whether the effect is permanent depends on the drug used, the cumulative dose, and your age at treatment. The conversation about fertility preservation should happen before the first cycle begins, not after.

In detail

Which chemotherapy drugs carry the highest fertility risk?

ASCO classifies alkylating agents as the highest-risk chemotherapy group for gonadotoxicity. This includes cyclophosphamide (brand names Endoxan and Cycram in India), ifosfamide (Holoxan, Ifomid), busulfan (Myleran), melphalan (Alkeran), and chlorambucil (Leukeran). The risk applies whether these drugs are used for solid tumours or blood cancers.

Platinum drugs — cisplatin and carboplatin, both widely available as generics in India — and the anthracycline doxorubicin are classified as moderate risk. For these drugs, the cumulative dose received over the course of treatment affects the likelihood and severity of fertility impact.

Drugs including vincristine and most taxanes carry lower fertility risk. Your full regimen matters as much as any single drug in it. Ask your oncologist for a specific risk assessment based on the combination being planned for you.

In detail

Is the damage to fertility permanent?

The damage can be permanent — and whether it is depends on the specific drug used, the total cumulative dose, and your age at treatment.

In women, chemotherapy can destroy the follicles stored in the ovaries. Follicles do not regenerate once lost. If enough are destroyed, periods stop and do not return — a condition called premature ovarian insufficiency. A return of periods after treatment does not guarantee that fertility has also returned.

In men, chemotherapy suppresses sperm production. Unlike eggs, sperm are produced continuously, so recovery is possible. But it is not guaranteed, and can take months to years even after treatment with a moderate-risk drug.

Eligibility

Who is chemotherapy not suitable for?

Chemotherapy is not appropriate in every situation. Eligibility is decided by an oncologist based on the individual case — diagnosis, blood results, organ function tests, and overall health.

People whose cancer has not been confirmed by tissue biopsy or other diagnostic tests.
People with severely impaired kidney or liver function, as most chemotherapy drugs must be cleared safely by these organs.
People with very poor performance status, where treatment risk is judged to outweigh likely benefit.
People in the first trimester of pregnancy; later trimesters may be possible with careful specialist review.
People with active, uncontrolled serious infectionTreatment is usually deferred until the infection is resolved.
People who have already received certain drugs up to their safe cumulative dose limit.

Your oncologist reviews your full medical picture before deciding which treatment, if any, is appropriate for you.

Want to talk this through with an oncologist?

Leave your number and an oncology coordinator will call you back at a time that suits you.

In detail

Does your age at the time of treatment make a difference?

Yes — for women, age at the time of treatment makes a significant difference. A younger woman has a larger ovarian reserve, giving her a greater chance of ovarian function returning after treatment.

A woman who is closer to natural menopause starts with fewer follicles. Even a moderate fertility impact can tip her into permanent early menopause. This does not change whether treatment is recommended, but it increases the urgency of the fertility preservation conversation.

For men, age matters less than the drug and cumulative dose. Younger men tend to recover more fully when recovery does occur, but the most important factors are what drug was used and how much was given in total.

Step by step

What should you do about fertility before chemotherapy starts?

Raise it at your next appointment

Tell your oncologist you want to discuss fertility before treatment begins. This conversation needs to happen before the first cycle, not after. ASCO guidance recommends that oncologists raise this with all patients of reproductive age — if they have not, you can raise it yourself.

Ask for a referral to a reproductive medicine specialist

Your oncologist and a fertility specialist need to coordinate. The timing of any preservation procedure is set by your cancer treatment plan — the two teams need to agree together.

For men: arrange sperm banking

A semen sample can be stored before the first dose. This typically takes one visit and is the most reliable and established option available to men facing gonadotoxic chemotherapy.

For women: discuss egg or embryo freezing

Oocyte or embryo cryopreservation is the most established fertility preservation option for women. It requires a stimulation cycle of roughly two weeks. Discuss whether the timing is feasible with your oncology team.

Ask about ovarian tissue freezing if time is short

When there is not enough time for a stimulation cycle, ovarian tissue can sometimes be removed and frozen before treatment starts. This is a specialist procedure offered at select centres and should be discussed with your team specifically.

Do not delay cancer treatment to explore every option

Fertility preservation is a time-sensitive conversation, but it should not significantly delay your cancer treatment. Your oncology and fertility teams will agree on a safe timeline together.

Question by question

What else should families know about chemotherapy and fertility?

Can a woman conceive naturally after chemotherapy?

Some women do, usually when ovarian function returns after treatment with lower- or moderate-risk drugs. Whether that is possible depends on the drugs used, the cumulative dose, and age at treatment. ASCO and ESMO guidance advises waiting at least one to two years after completing treatment before attempting conception, to allow ovarian function to stabilise and to be more confident the cancer is in remission. Your oncologist can give you a more individual assessment once treatment is complete.

Is a pregnancy conceived after chemotherapy safe for the baby?

Evidence reviewed by ASCO and ESMO does not show an increased rate of birth defects in children conceived after a parent completed chemotherapy, provided a sufficient interval has passed since the last dose. The drugs clear the body; the risk is not carried into conception. Discuss the timing with both your oncologist and an obstetrician, as the recommended interval differs by drug and by how well the cancer has responded to treatment.

What is a GnRH agonist, and does it protect fertility during chemotherapy?

A GnRH agonist — such as leuprolide or goserelin — temporarily suppresses ovarian activity during chemotherapy, which may reduce the impact on the follicle pool. ASCO guidance notes that GnRH agonists may reduce the risk of premature ovarian insufficiency in some settings. The evidence is mixed, and they are not considered a substitute for established fertility preservation such as egg or embryo freezing when that option is available.

What if there is no time to preserve fertility before treatment?

Some diagnoses require treatment to start within days, which may not leave time for fertility preservation. Your oncologist should note your fertility concerns in your record. Some options remain available after treatment ends — including ovarian tissue transplantation for women who had tissue stored, and hormone therapy for menopausal symptoms. Being told there is no time before treatment is not the end of the conversation about fertility.

Does radiation also damage fertility?

Yes. Radiation directed at or near the pelvis carries significant fertility risk, managed separately from chemotherapy. Radiation to the brain can suppress the hormones that control ovarian and testicular function. If your treatment plan includes both chemotherapy and radiation, ask your team to address fertility risk from both components separately — the combined impact may be greater than either alone.

Still have a question about your treatment? Tell us what is on your chart and an oncologist will explain what it means for you, what to expect and what your schedule is likely to look like.

Talk to an oncologist 1800 202 8726

Common questions

Frequently asked questions

Are alkylating agents the only chemotherapy drugs that can cause infertility?

No, but they carry the highest risk. ASCO classifies alkylating agents — cyclophosphamide, ifosfamide, busulfan, melphalan, and chlorambucil — in the high-risk category for gonadotoxicity. Platinum drugs and anthracyclines such as doxorubicin carry moderate risk. Most taxanes and vinca alkaloids carry lower risk. Your full regimen is what matters — no chemotherapy combination is without any risk, and your oncologist can give you an assessment based on the specific drugs and doses planned for you.

How long after chemotherapy can you try to conceive?

Most guidance, including from ASCO and ESMO, recommends waiting at least one to two years after completing treatment. This allows time for ovarian function to stabilise if it is going to return, for any residual drug effects to resolve, and for your oncologist to be more confident that the cancer is in remission. The right interval depends on your specific treatment and your cancer type, so agree the timing with your oncologist before making any decision.

Does chemotherapy always cause permanent menopause in women?

Not always, but high-risk drugs — particularly alkylating agents at high cumulative doses — can cause premature ovarian insufficiency, which functions like early menopause and may be permanent. Whether this happens depends on the drug, the cumulative dose, and your age at treatment. Some women see their periods return after treatment ends; for others they do not. A return of periods is not a guarantee of fertility. Your oncologist can give you a more specific risk estimate before treatment begins.

Can men always bank sperm before chemotherapy?

In most cases, yes. Sperm banking before the first dose is straightforward, typically requiring one or two visits, and is the most reliable option for men facing gonadotoxic chemotherapy. The main exceptions are when treatment must start urgently within days, or when semen analysis shows no viable sperm. In some cases, sperm can be retrieved directly from testicular tissue — a specialist procedure not available at every centre. Ask your oncologist to arrange a referral to a fertility service as early as possible.

Will my oncologist raise fertility automatically, or do I need to ask?

ASCO guidance recommends that oncologists raise fertility preservation with all patients of reproductive age before starting treatment. In practice this does not always happen — sometimes because the immediate focus is on the diagnosis, sometimes because it is assumed the patient will not want to discuss it. You have every right to raise it yourself. Asking the question at your next appointment is the most important step, because options narrow or disappear once chemotherapy has begun.

Is fertility preservation available in India?

Yes. Sperm banking is available at most major hospitals and fertility clinics across Hyderabad, Bangalore, Mumbai, Chennai, and other cities. Egg and embryo freezing are offered at fertility centres in all major cities, though experience with oncofertility — preservation specifically for patients starting cancer treatment — varies between centres. Ask your oncologist for a referral to a reproductive medicine team with experience in cancer cases, as the protocols and timing considerations differ from standard fertility treatment.

Who would be treating you

The medical oncologists on the CION panel

Chemotherapy is prescribed, dosed and supervised by a medical oncologist. These are the six on the CION panel.

Dr. Naresh Gundu

Medical Oncologist

MBBS · DNB Internal Medicine (Sir Gangaram, New Delhi) · DM Medical Oncology (AIIMS)

Call Book appointment

Dr. C. Raghavendra Reddy

Medical Oncologist

MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Kukatpally

Call Book appointment

Dr. Bharati Devi Gorantla

Medical Oncologist

MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK)

Call Book appointment

Dr. Owais Mohammed

Medical Oncologist

Call Book appointment

Dr. T. Raghavender Reddy

Medical Oncologist

MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · L.B. Nagar

Call Book appointment

Dr. N. Kiranmayee

Medical Oncologist

Call Book appointment

Which oncologist you see depends on the centre nearest you and on what your treatment involves. Tell us where you are and we will point you to the closest.

Talk it through

Reading about a medicine is not the same as being told what to expect

This page explains what the medicine does in general. What it cannot tell you is how your own regimen was chosen, what your schedule looks like, or which of these effects apply to you — that needs your reports and a conversation.

Free first consultation Second opinion on an existing plan 10 centres across Hyderabad

Speak to an oncologist

Share your details and the team will call you back to arrange a consultation or a second opinion.

Bring your reports if you have them. If you do not, come anyway.

list of links to other editorial pages, which base contract s2.1 permits explicitly. It contains no form, no phone number and no CTA button, so it does not turn this page into an advertisement. Generated by scripts/hub_update.py --include-out. -->

Full index